Physician profile
Derek Evans Engle
NPI 1518595834
$806.43
in general payments reported to CMS, 2019-2025
9 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.45 · 2022: $144 · 2023: $46.64 · 2024: $123 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $358.55 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Davol INC. | $161.89 | 2025 | Arista |
| Boston Scientific Corporation | $123.14 | 2024 | Spyglass Discover |
| Solventum Corporation | $48.19 | 2025 | Prevena, V.A.C.Ulta, Promogran |
| Kci USA, INC. | $31.28 | 2022 | |
| Medtronic, INC. | $23.61 | 2023 | Endurant Iis |
| Ethicon US, LLC | $23.29 | 2025 | Surgiflo Hemostatic Matrix, Evarrest, Dermabond |
| Shockwave Medical, INC | $23.03 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pacira Pharmaceuticals Incorporated | $13.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Engle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.